Skip to main content
Equibles

ELEVATION POINT WEALTH PARTNERS, LLC

Position in CGTX — Cognition Therapeutics Inc

CIK 1744349 DENVER, CO
Back to CGTX Full portfolio

Position in CGTX

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$11,546
+$3,916 QoQ
Shares Held
10,040
0.0% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#52
of 66 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in CGTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ELEVATION POINT WEALTH PARTNERS, LLC holds $12,657,390 across 22 Biotechnology names. CGTX ranks #22 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 NTLA
Intellia Therapeutics, Inc.
 188,207 $3,184,462
2 ARWR
Arrowhead Pharmaceuticals, Inc.
 16,991 $1,384,936
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,252 $1,118,635
4 DNTH
Dianthus Therapeutics, Inc. /DE/
 8,902 $867,766
5 REGN
Regeneron Pharmaceuticals, Inc.
 1,241 $773,813
6 ABVX
Abivax S.A.
 5,256 $700,414
7 DFTX
Definium Therapeutics, Inc.
 11,382 $535,409
8 AXSM
Axsome Therapeutics, Inc.
 1,847 $452,090

All Filings in CGTX

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $11,546 10,040
2026-03-31 $7,630 10,040